[Fibrin deposits in Masugi nephritis and effects of urokinase, non-steroidal anti-inflammatory agents, anti-inflammatory enzymes and prostaglandins].
D000818:Animals; D005337:Fibrin / Q000378:metabolism*; D005921:Glomerulonephritis / Q000188:drug therapy*; D007213:Indomethacin / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000378:metabolism; D009113:Muramidase / Q000627:therapeutic use*; D011453:Prostaglandins / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D011453:Prostaglandins; D005337:Fibrin; D009113:Muramidase; D014568:Urokinase-Type Plasminogen Activator; D007213:Indomethacin